S Nebel

2.2k total citations · 1 hit paper
10 papers, 1.5k citations indexed

About

S Nebel is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Oncology. According to data from OpenAlex, S Nebel has authored 10 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 6 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in S Nebel's work include Genetic factors in colorectal cancer (9 papers), DNA Repair Mechanisms (6 papers) and Cancer Genomics and Diagnostics (4 papers). S Nebel is often cited by papers focused on Genetic factors in colorectal cancer (9 papers), DNA Repair Mechanisms (6 papers) and Cancer Genomics and Diagnostics (4 papers). S Nebel collaborates with scholars based in United States and Switzerland. S Nebel's co-authors include Daniel Fink, Stefan Aebi, A Nehmé, R D Christen, Stephen B. Howell, Bruno Cenni, S B Howell, Hua Zheng, C. Richard Boland and John M. Carethers and has published in prestigious journals such as Gastroenterology, British Journal of Cancer and International Journal of Cancer.

In The Last Decade

S Nebel

10 papers receiving 1.4k citations

Hit Papers

The role of DNA mismatch repair in platinum drug resistance. 1996 2026 2006 2016 1996 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Nebel United States 10 916 816 744 390 162 10 1.5k
Meenakshi Dabholkar United States 14 463 0.5× 240 0.3× 686 0.9× 217 0.6× 116 0.7× 24 1.1k
Sajeev Cherian United States 11 470 0.5× 593 0.7× 638 0.9× 351 0.9× 90 0.6× 16 1.1k
Barry Cukor United States 7 1.1k 1.3× 227 0.3× 943 1.3× 229 0.6× 164 1.0× 9 1.6k
Allyson L. Parr United States 12 711 0.8× 250 0.3× 305 0.4× 178 0.5× 153 0.9× 15 1.0k
Maria Pia Morelli United States 19 863 0.9× 272 0.3× 449 0.6× 350 0.9× 113 0.7× 70 1.3k
Michio Sugita Japan 12 561 0.6× 115 0.1× 810 1.1× 389 1.0× 63 0.4× 32 1.3k
S Ritland United States 12 235 0.3× 228 0.3× 444 0.6× 245 0.6× 67 0.4× 22 965
Anne-Renee Hartman United States 10 648 0.7× 187 0.2× 491 0.7× 479 1.2× 69 0.4× 11 1.1k
Iván Díaz-Padilla United States 21 728 0.8× 215 0.3× 634 0.9× 392 1.0× 91 0.6× 53 1.4k
Yusuke Nakamura Japan 9 569 0.6× 249 0.3× 742 1.0× 250 0.6× 56 0.3× 9 1.1k

Countries citing papers authored by S Nebel

Since Specialization
Citations

This map shows the geographic impact of S Nebel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Nebel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Nebel more than expected).

Fields of papers citing papers by S Nebel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Nebel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Nebel. The network helps show where S Nebel may publish in the future.

Co-authorship network of co-authors of S Nebel

This figure shows the co-authorship network connecting the top 25 collaborators of S Nebel. A scholar is included among the top collaborators of S Nebel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Nebel. S Nebel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Fink, Daniel, et al.. (1999). Decreased cisplatin damage-dependent DNA synthesis in cellular extracts of mismatch repair deficient cells. Biochemical Pharmacology. 57(8). 861–867. 15 indexed citations
2.
Nehmé, A, Rathinasamy Baskaran, S Nebel, et al.. (1999). Induction of JNK and c-Abl signalling by cisplatin and oxaliplatin in mismatch repair-proficient and -deficient cells. British Journal of Cancer. 79(7-8). 1104–1110. 87 indexed citations
3.
Carethers, John M., Dharam P. Chauhan, Daniel Fink, et al.. (1999). Mismatch repair proficiency and in vitro response to 5-fluorouracil. Gastroenterology. 117(1). 123–131. 345 indexed citations
4.
Fink, Daniel, et al.. (1998). The effect of different chemotherapeutic agents on the enrichment of DNA mismatch repair-deficient tumour cells. British Journal of Cancer. 77(5). 703–708. 68 indexed citations
5.
Fink, Daniel, S Nebel, Paula S. Norris, et al.. (1998). Enrichment for DNA mismatch repair-deficient cells during treatment with cisplatin. International Journal of Cancer. 77(5). 741–746. 64 indexed citations
6.
Fink, Daniel, S Nebel, Stefan Aebi, et al.. (1997). Expression of the DNA mismatch repair proteins hMLH1 and hPMS2 in normal human tissues. British Journal of Cancer. 76(7). 890–893. 24 indexed citations
7.
Fink, Daniel, Hongtu Zheng, S Nebel, et al.. (1997). In vitro and in vivo resistance to cisplatin in cells that have lost DNA mismatch repair.. PubMed. 57(10). 1841–5. 232 indexed citations
8.
Fink, Daniel, S Nebel, Stefan Aebi, A Nehmé, & Stephen B. Howell. (1997). Loss of DNA mismatch repair due to knockout of MSH2 or PMS2 results in resistance to cisplatin and carboplatin. International Journal of Oncology. 11(3). 539–42. 26 indexed citations
9.
Nehmé, A, Rathinasamy Baskaran, Stefan Aebi, et al.. (1997). Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin.. PubMed. 57(15). 3253–7. 110 indexed citations
10.
Fink, Daniel, S Nebel, Stefan Aebi, et al.. (1996). The role of DNA mismatch repair in platinum drug resistance.. PubMed. 56(21). 4881–6. 512 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026